# | Title | Journal | Year | Citations |
---|
1 | Pregnancy after transplantation | Transplantation Reviews | 2008 | 287 |
2 | Current strategies to minimize hepatic ischemia–reperfusion injury by targeting reactive oxygen species | Transplantation Reviews | 2012 | 248 |
3 | Scientific Registry of Transplant Recipients: Collecting, analyzing, and reporting data on transplantation in the United States | Transplantation Reviews | 2013 | 246 |
4 | Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides | Transplantation Reviews | 1992 | 241 |
5 | Strategies for the management of adverse events associated with mTOR inhibitors | Transplantation Reviews | 2014 | 233 |
6 | Lymphocytes and ischemia-reperfusion injury | Transplantation Reviews | 2009 | 184 |
7 | Proteinuria: detection and role in native renal disease progression | Transplantation Reviews | 2012 | 178 |
8 | Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management | Transplantation Reviews | 2015 | 161 |
9 | COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature | Transplantation Reviews | 2021 | 159 |
10 | The Impact of Ischemia/Reperfusion Injury on Specific and Non-Specific, Early and Late Chronic Events After Organ Transplantation | Transplantation Reviews | 1996 | 154 |
11 | Kaposi sarcoma in transplantation | Transplantation Reviews | 2008 | 123 |
12 | ABO-incompatible kidney transplantation | Transplantation Reviews | 2013 | 118 |
13 | Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure | Transplantation Reviews | 2011 | 116 |
14 | Organ donation in the US and Europe: The supply vs demand imbalance | Transplantation Reviews | 2021 | 113 |
15 | Antibody-mediated rejection: treatment alternatives and outcomes | Transplantation Reviews | 2009 | 110 |
16 | Immunosuppression for kidney transplantation: Where are we now and where are we going? | Transplantation Reviews | 2017 | 107 |
17 | Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations | Transplantation Reviews | 2018 | 104 |
18 | mToR inhibitors-induced proteinuria: mechanisms, significance, and management | Transplantation Reviews | 2008 | 103 |
19 | Current status of ischemia and reperfusion injury in the liver | Transplantation Reviews | 2000 | 100 |
20 | Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas | Transplantation Reviews | 2011 | 95 |
21 | Effects of brain death on organ quality and transplant outcome | Transplantation Reviews | 2012 | 95 |
22 | Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations | Transplantation Reviews | 2016 | 95 |
23 | Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection | Transplantation Reviews | 2009 | 94 |
24 | Cancers after renal transplantation | Transplantation Reviews | 2008 | 90 |
25 | Immunosuppressive therapies after heart transplantation — The balance between under- and over-immunosuppression | Transplantation Reviews | 2015 | 88 |
26 | Strategies to optimize deceased organ donation | Transplantation Reviews | 2007 | 87 |
27 | Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury | Transplantation Reviews | 2010 | 87 |
28 | The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury | Transplantation Reviews | 2012 | 87 |
29 | Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantation | Transplantation Reviews | 1993 | 85 |
30 | Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation | Transplantation Reviews | 2013 | 83 |
31 | New concepts and best practices for management of pre- and post-transplantation cancer | Transplantation Reviews | 2012 | 82 |
32 | Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis | Transplantation Reviews | 2008 | 80 |
33 | The collaborative transplant study registry | Transplantation Reviews | 2013 | 79 |
34 | Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation | Transplantation Reviews | 2019 | 76 |
35 | Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation | Transplantation Reviews | 2013 | 74 |
36 | Role of mesenchymal stromal cells in solid organ transplantation | Transplantation Reviews | 2008 | 72 |
37 | Monocytes/macrophages in renal allograft rejection | Transplantation Reviews | 2009 | 72 |
38 | Fungal infections after lung transplantation | Transplantation Reviews | 2008 | 69 |
39 | Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications | Transplantation Reviews | 2012 | 68 |
40 | Patient outcomes after kidney allograft loss | Transplantation Reviews | 2008 | 67 |
41 | Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up | Transplantation Reviews | 2014 | 67 |
42 | Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis | Transplantation Reviews | 2018 | 67 |
43 | Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation | Transplantation Reviews | 2011 | 66 |
44 | Emerging role of innate immunity in organ transplantation Part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells | Transplantation Reviews | 2012 | 66 |
45 | Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting | Transplantation Reviews | 2011 | 65 |
46 | The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen | Transplantation Reviews | 2012 | 65 |
47 | mTOR inhibitor–associated proteinuria in kidney transplant recipients | Transplantation Reviews | 2012 | 65 |
48 | The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients | Transplantation Reviews | 2014 | 65 |
49 | Minor histocompatibility antigens in man and their role in transplantation | Transplantation Reviews | 1988 | 64 |
50 | Liver disease related to the heart | Transplantation Reviews | 2015 | 62 |